
1 minute read
Spaces
VirdisGroup: Bringing the right talent and innovation support to community members VirdisGroup helps its partners to identify, engage and hire top talent through its life sciences executive search service. It also offers InvestConnect, using its expertise to provide support to leverage technology and help its clients move to the next level
In 2022, VirdisGroup worked in close collaboration with Biopôle member Legacy Healthcare. Legacy Healthcare aims to develop novel drugs for autoimmune, inflammatory and ageing-related conditions, safe enough for chronic use especially by more fragile individuals, for example children or cancer patients. Its first drug, Coacillium, is currently in phase 2/3 testing for the treatment of alopecia areata. Legacy Healthcare is working with VirdisGroup to find the right talent to add value to the business as it grows.
Advertisement
Meanwhile, Biopôle-based Exogems has been working with VirdisGroup as part of its InvestConnect service. The early-stage Swiss biotech company plans to exploit the therapeutic potential of exosomes, small vesicles found in eukaryotic fluids, aiming to develop yields with proven clinical efficiency against glioblastoma. Dr Carmelo Bisognano, VirdisGroup’s Investor & New Companies Relations Lead, has been elected CEO of Exogems to structure and manage the company in the early preclinical stage phase and create value for the successive financial and clinical steps.
Vivactis Switzerland: Experts in the life sciences market
Vivactis Switzerland is a marketing and communication agency exclusively focused on healthcare and life sciences. It offers services to companies, clinics, hospitals, research centres and NGOs, covering pharma, biotech, medtech, diagnostics, nutrition and digital health. It supports its clients with market access and marketing strategies; medical marketing and communications, education and writing; clinical studies; and direct-to-patient information and patient coaching programmes.
In 2022, Vivactis supported biped.ai to prepare the launch of its device, a smart harness worn on shoulders that uses self-driving technology to guide visually impaired individuals. Vivactis helped with medical and target analysis, leading to a prelaunch positioning statement, a full corporate communication plan and a marketing strategy.
Genknowme works on developing an innovative blood test that identifies key epigenetic markers. In the context of a grant submission, Vivactis provided the company with support for market analysis (market identification, medical context analysis and business opportunities) and a marketing plan.
Vivactis also conducted a complete literature review and edited a report summarising scientific articles, which Distalmotion, a medical devices company specialising in robotic surgery, can include in its clinical study activities.